Cryptocurrency & Digital Assets

A top global forum warns of politicized trade and tech divides. How will this impact pharma supply chains, AI in medicine, and market access?

Netcapital's huge 1M share grant to its new CEO is a high-stakes play. We decode the strategy, the risk, and the ambitious revenue targets.

As Thailand braces for another toxic smog season, air purifier giant Levoit deploys a timely strategy to capture a market born from a public health crisis.

Guangdong Jiaying Pharma is leveraging its unique Hakka heritage to enter the global market. But can ancient wisdom navigate modern regulatory and corporate hurdles?

A deep dive into 22 Fulton Street, where complex finance, green design, and affordable housing converge to reshape Newark's skyline and its community.

Imviva Biotech's 'off-the-shelf' cell therapies could make life-saving treatments faster and more accessible. But what does this mean for patients?

With its AI & Autonomy Day, Rivian is betting its future on software. Investors are watching to see if its tech can deliver a true competitive edge.

With its finances in distress, Netcapital bets its future on blockchain and a new CEO. Can a turnaround specialist navigate the crypto frontier?

As it readies for a SPAC merger, quantum leader Infleqtion hires a top aerospace veteran to scale its sensing unit for defense and commercial markets.

When a 'living drug' for cancer fails, hope fades. A new biologic aims to repaint the target, giving patients' own immune cells a second chance to win.

Beyond the lavish anniversary party, the Chinese spirits giant is leveraging a century of history in a sophisticated bid to conquer the Western market.

A new point-of-care PCR test is moving closer to reality in India, promising to revolutionize the fight against tuberculosis and cervical cancer.

A breakthrough therapy using the gut microbiome shows a 54% survival rate for a fatal transplant complication, heralding a new era in oncology treatment.

Prospect Enhanced Yield Fund's debut 9% distribution tempts income seekers, but a look into the structured credit market reveals a complex risk-reward.

A key regulatory filing reveals First Trust Advisors' major stake in NCC Group, fueling speculation as the UK cybersecurity firm weighs a potential sale.

A hedge fund's subtle move in Unite Group offers a rare glimpse into the high-stakes strategy behind the UK's student housing consolidation boom.

Beyond the press release: Why Terreno's 107,000 sq. ft. deal with the Secret Service is a major indicator for the industrial real estate market.

A massive natural gas pipeline aims to fuel Nevada's tech boom. But does this $1.7 billion bet on fossil fuels conflict with the state's green energy future?

A new clinical trial in Malaysia could democratize advanced cancer care, testing an affordable, donor-derived immunotherapy challenging costly personalized treatments.

Enterprises lose up to 9% of revenue from missed contract obligations. New AI tools are turning static legal documents into actionable intelligence.